\
&
Contact us
\
&
Contact us
Published on | 2 years ago
ProgrammesThe purpose of the Large AI Grand Challenge is to foster the development of large-scale AI models in Europe and to substantially increase the visibility of Europe’s activity in this field.
The competition will reward innovative startups and SMEs for devising ambitious strategies and making commitments to develop large-scale AI models that will provide a competitive edge for Europe.
The expected outcome of the Large AI Grand Challenge is the selection of up to four proposals that will receive each up to 250 k€ in funding to create innovative foundational language models that will outperform state-of-the-art systems in a number of relevant tasks. The development of these models should necessarily involve the use of High-Performance Computing (HPC). The submission deadline is 16 January 2024.
To be eligible to apply to the Large AI Grand Challenge, applicants must meet the four following criteria:
Full information can be found on the call website.
Extra: there is an info session on 12 December.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
